Background illustration for clinical trials search

Paid Clinical Trials Nashville

Discover 1,239 paid clinical trials in Nashville, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

An Open-label Dose Escalation/Expansion Trial to Evaluate the Safety and Anti-tumor Activity of TEV-56278 Alone or in Combination With Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors

for
Advanced Solid Tumors
Location: Nashville TN, Cincinnati OH, Huntersville NC,
Sponsor: Teva Branded Pharmaceutical Products R&D LLC

Sex: All

Age: 18+

Code: NCT06480552

Phase 1, Recruiting

Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis

for
Primary Myelofibrosis,
Location: Nashville TN, Ann Arbor MI, Houston TX, New York NY,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT06517875

Phase 2, Recruiting

A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)

for
Neoplasms
Location: Nashville TN, Fort Wayne IN, Myrtle Beach SC,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT06551142

Phase 1, Recruiting

To Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of DAY301 in Participants With Locally Advanced or Metastatic Solid Tumors

for
Advanced or Metastatic Solid Tumors
Location: Nashville TN, Avon IN, Grand Rapids MI,
Sponsor: Day One Biopharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT06752681

Phase 1, Recruiting

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

for
Advanced Solid Tumors
Location: Nashville TN, Louisville KY, Atlanta GA, Cincinnati OH,
Sponsor: DualityBio Inc.

Sex: All

Age: 18+

Code: NCT05914116

Phase 1, Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Phase 1 Study of BHV-1530 in Advanced Solid Tumors

for
Solid Tumor
Location: Nashville TN, Durham NC, Ann Arbor MI, Cleveland OH,
Sponsor: Biohaven Therapeutics Ltd.

Sex: All

Age: 18+

Code: NCT06874335

Phase 1, Recruiting

A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Nashville TN, Germantown TN, Cleveland OH,
Sponsor: Exelixis

Sex: All

Age: 18+

Code: NCT05932862

Phase 1, Recruiting

A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease

for
Graves' Disease
Location: Nashville TN, Bowling Green KY, Chattanooga TN,
Sponsor: Immunovant Sciences GmbH

Sex: All

Age: 18 - 70+

Code: NCT06727604

Phase 2, Recruiting

A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)

for
Solid Tumors, Neoplasms
Location: Nashville TN, Birmingham AL, Fairway KS, Detroit MI,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT06431594

Phase 1, Recruiting

First-in-human Study of DB-1419 for Advanced/Metastatic Solid Tumors

for
Solid Tumor, Adult
Location: Nashville TN, Huntersville NC, Chicago IL,
Sponsor: DualityBio Inc.

Sex: All

Age: 18+

Code: NCT06554795

Phase 1, Phase 2, Recruiting

A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Standard of Care in Participants With Relapsed-Refractory Multiple Myeloma (RRMM)

for
Multiple Myeloma
Location: Nashville TN, Bridgeton MO, Macon GA, Springfield MO,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT07227311

Phase 2, Recruiting

A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma

for
Solid Tumors
Location: Nashville TN, Atlanta GA, Springfield IL, Salem VA,
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT07522073

Phase 3, Recruiting

A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors

for
Neoplasms, Colorectal, Neoplasms
Location: Nashville TN, Canton OH, Detroit MI, Hamilton, Toronto,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT07213609

Phase 1, Phase 2, Recruiting

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

for
Renal Cell Carcinoma (RCC),
Location: Nashville TN, Indianapolis IN, Chicago IL, Durham NC,
Sponsor: Exelixis

Sex: All

Age: 18+

Code: NCT05176483

Phase 1, Recruiting

Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma

for
Adenocarcinoma, Carcinoma, Pancreatic Ductal
Location: Nashville TN, Atlanta GA, Cincinnati OH, Goshen IN,
Sponsor: Corcept Therapeutics

Sex: All

Age: 18+

Code: NCT07259317

Phase 2, Recruiting

A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tumors

for
Neoplasms
Location: Nashville TN, Dallas TX, Reunion FL, Philadelphia PA,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT07277270

Phase 1, Recruiting

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

for
HNSCC, ESCC, Esophageal Adenocarcinoma, Gastric Adenocarcinoma,
Location: Nashville TN, St Louis MO, Maumee OH, Charleston SC,
Sponsor: Normunity AccelCo, Inc.

Sex: All

Age: 18+

Code: NCT07182149

Phase 1, Recruiting

Study to Evaluate the Safety of Retreatment With Restylane® Lyft With Lidocaine for Augmentation of the Chin Region

for
Chin Augmentation
Location: Nashville TN, Atlanta GA, Spring TX, Boynton Beach FL,
Sponsor: Galderma R&D

Sex: All

Age: 22+

Code: NCT07566286

Recruiting

A Dose-masked Study of Intravitreal Remigromig (EYE103) in Participants With NVAMD or Macular Edema Following BRVO

for
Neovascular Age-Related Macular Degeneration (NVAMD),
Location: Nashville TN, Knoxville TN, Germantown TN, Asheville NC,
Sponsor: EyeBiotech Ltd.

Sex: All

Age: 18+

Code: NCT07205887

Phase 2, Recruiting

Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors

for
Advanced Solid Tumor, Metastatic Solid Tumor, Prostate Cancer,
Location: Nashville TN, St Louis MO, Lake Mary FL,
Sponsor: MOMA Therapeutics

Sex: All

Age: 18+

Code: NCT06545942

Phase 1, Recruiting